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Abstract 
Objective: To use an established cohort of boys to investigate common patterns of 
malformations in those with hypospadias. 
Method: Retrospective review of the phenotype of participants in the Deciphering 
Developmental Disorders (DDD) Study with neurodevelopmental delay and an 
‘Abnormality of the genital system’. This group was divided into two subgroups: those 
with hypospadias and without hypospadias. Associated phenotypes of the two subgroups 
were compared and analysed.  
Results: Of the 166 DDD participants with hypospadias and neurodevelopmental delay, 
47 (28%) had cardiovascular (CVS) and 40 (24%) had structural brain abnormalities. The 
rate of CVS abnormalities in those with neurodevelopmental delay and genital 
abnormalities other than hypospadias (N=645) was lower at 19% (p=0.001). In addition, 
structural brain malformations were higher at 24% in the hypospadias group versus 15% 
in the group without hypospadias (p=0.002). The constellation of these features occured 
at a higher rate in the hypospadias group versus the no hypospadias group (p=0.038). 
Conclusions: In summary, this is the first study to indicate that cardiovascular and brain 
abnormalities are frequently encountered in association with hypospadias in children with 
neurodevelopmental disorders. Not only do these associations provide insight into the 
underlying aetiology but they highlight the multisystem involvement in conditions with 
hypospadias. 
 
Keywords – Brain, Cardiac, Disorders of sex development, DSD, Genitalia  
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Introduction 
Disorders of sex development (DSD) are a group of conditions in which the 
chromosomal, gonadal and/ or phenotypic sex is atypical.(Lee et al., 2006) Hypospadias 
is one of the most common physical presentations of DSD(Ahmed et al., 2004) and while 
it may occur in isolation or in combination with other abnormalities of the external 
genitalia, in many cases, it may also be associated with several other developmental 
abnormalities.(Cox et al., 2014) Although the aetiology of hypospadias may be attributed 
to endocrine, environmental and genetic factors,(Yang et al., 2014) in the majority of 
cases, a single identifiable cause is not clear.(Fernandez et al., 2016) Over the last decade, 
many genetic conditions associated with DSD have been reported to be associated with 
extra-genital malformations.(Fernandez et al., 2016, Friedman et al., 2008, Latifoglu et 
al., 1998, Wu et al., 2002, Lin et al., 2014, Shima et al., 1979) A clear knowledge of 
common patterns of congenital malformations that could be associated with DSD has the 
potential to provide clues that may pinpoint the underlying aetiology. Between 2011 and 
2015, the UK-wide Deciphering Developmental Disorders (DDD) study has relied on 
clinical geneticists to collect clinical information from over 13,000 undiagnosed patients 
presenting with a neurodevelopmental disorder in the UK. The primary aim of that study 
had been to identify the underlying molecular diagnosis, but it has also enabled the 
investigators to create a phenotypic database of the participants which could be used for 
complementary analyses.(Firth and Wright, 2011) Some phenotypic features of DSD can 
be relatively subjective such as small phallus, scrotal fusion and undescended testes and 
others, such as hypospadias, can be clearly identified. Given that hypospadias may be 
present in over three-quarters of cases of atypical genitalia that are associated with a 
DSD,(Ahmed et al., 2004) the aim of the current study was to study the range of 
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associated anomalies that may occur in children with neurodevelopmental anomalies and 
DSD, and within this group compare those with hypospadias to those without 
hypospadias. Analysis of these data would allow the identification of common 
constellations of congenital anomalies that may exist in such children.  
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Patients & Methods  
Phenotypic Data Collection 
The phenotypic data collated by the DDD study were entered into the study's secure 
website, DECIPHER, using Human Phenotype Ontology (HPO) terms to standardise the 
description of the observed features of the patients; hence, the choice of feature 
description was limited to the terms available within this ontological classification. 
Phenotypic data from cases recruited from April 2011 until May 2014 with at least one 
HPO term under ‘Abnormality of the genital system' (HP:0000078) were selected. A total 
number of 324 HPO terms were identified within this category in 1092 DDD participants. 
The subset of this group with hypospadias was ascertained by selecting those with the 
HPO terms hypospadias (HP: 0000047), glandular hypospadias (HP:0000807), coronal 
hypospadias (HP:0008743), penile hypospadias (HP:0003244), penoscrotal hypospadias 
(HP:0000808) and perineal hypospadias (HP:0000051). All other participants with an 
abnormality of the genital system other than hypospadias were included in the ‘no 
hypospadias’ group. Given that the majority of the DDD cohort have a 
neurodevelopmental delay phenotype, to standardise the two sub-cohorts of hypospadias 
and no-hypospadias cases, only individuals with at least one of 20 HPO terms (Table 1) 
describing a neurodevelopmental delay phenotype were included in the current study. 
Ethics approval was granted by the Cambridge South REC (10/H0305/83) and the 
Republic of Ireland REC (GEN/284/12). 
 
Data Analysis 
P values of the two proportion test were calculated using the GraphPad QuickCalcs 
website: https://www.graphpad.com/quickcalcs/contingency1.cfm (accessed May 2018). 
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In addition, Minitab statistical software [Version 18, 2017, Minitab, Inc. 
(www.minitab.com) State College, PA] was used to perform two proportion test to 
determine how the proportions of individuals with a particular associated phenotype of 
the two groups (hypospadias and no hypospadias) differed from each other. P values 
derived from the Fisher exact and two proportion tests were calculated. The significance 
level (alpha) was set at 0.05 and p<0.05 was considered to be statistically significant. P 
values from the 2 proportion test were calculated only for those disease categories where 
p values from the Fisher exact test were significant (p<0.05).  
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Results 
Cases of neurodevelopmental delay & hypospadias 
Of the 13,632 DDD recruits, 1092 (8%) cases were recorded to have an ‘Abnormality of 
the genital system’ and were selected for inclusion. Of these 1092 participants, 245 (22%) 
were recorded to have hypospadias whilst 847 (78%) did not have any phenotype entries 
related to hypospadias. Of the 245 cases, 172 (70%) had isolated hypospadias whilst the 
others had a combination of the following genital anomalies: 41 (17%) had hypospadias 
and undescended testes, 18 (7%) had hypospadias combined with another genital 
malformation but not undescended testes and 14 (6%) had a combination of hypospadias, 
undescended testes and another form of DSD. Other DSD phenotypes included scrotal 
and penile abnormalities. 166 (68%) of 245 cases had a neurodevelopmental delay, and 
given that one of the inclusion criteria for the DDD study required the presence of a 
neurodevelopmental disorder, the high level of association of these cases of hypospadias 
with neurodevelopmental disorders represented the expected selection bias of the DDD 
cohort. Of the 166 cases with hypospadias and neurodevelopmental phenotype, 44 (26%) 
had more than one neurodevelopmental phenotype recorded (Figure 1). Of the 847 cases 
without hypospadias, 645 (76%) had a neurodevelopmental delay phenotype with 467 of 
these 645 (72%) having more than one neurodevelopmental phenotype entries (Figure 1). 
 
Extra-genital malformations in cases with hypospadias & neurodevelopmental delay 
In addition to hypospadias, cases of neurodevelopmental delay had several other 
congenital anomalies with ophthalmic and periorbital, skeletal and hand abnormalities 
being the most common associations (Figure 2). The disease category entitled ‘Other’ 
included various HPO phenotypes that were not possible to place in any other categories 
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and included disorders of limb, neck, voice, movement, EEG, biochemical, 
haematological, psychiatric abnormalities and others such as obesity or recurrent 
infections. However, comparison of cases with hypospadias and neurodevelopmental 
delay to cases without hypospadias but with another genital abnormality and a 
neurodevelopmental delay, revealed a strong association of the hypospadias cohort with 
cardiovascular (p=0.001) and structural brain abnormalities (p=0.002) (Table 2).  
 
Cardiovascular & brain phenotypes in cases with hypospadias & neurodevelopmental 
delay 
Of the 166 individuals with hypospadias and a neurodevelopmental delay phenotype, 47 
(28%) had at least one cardiovascular phenotype, 40 (24%) had at least one structural 
brain abnormality and 12 (7%) exhibited both a cardiovascular and a structural brain 
abnormality in addition to hypospadias and neurodevelopment delay. In contrast, only 23 
(3.6%) of the 645 individuals without hypospadias and a neurodevelopmental delay 
exhibited both a cardiovascular and a brain defect (p=0.038). The range of cardiovascular 
phenotypes encountered in the cases of neurodevelopmental delay with and without 
hypospadias were similar (Table 3). Likewise, no significant difference was observed in 
the range of structural brain phenotypes in the hypospadias compared to the no 
hypospadias group (Table 3). 
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Discussion 
This retrospective review of associated features of DDD participants with hypospadias 
and neurodevelopmental delay not only confirms the previous observation that conditions 
such as hypospadias are often associated with additional malformations(Cox et al., 2014) 
but it also revealed that the coexistence of hypospadias and neurodevelopmental delay 
with cardiovascular and structural brain abnormalities represented a distinct constellation. 
In this study we selected DDD participants with DSD and neurodevelopmental delay and 
compared associated phenotypes of those with hypospadias to those without hypospadias. 
Since the description of some of the genital abnormalities such as penile length, scrotal 
abnormalities or undescended testes can be subjective, our aim was to select a DSD 
phenotype with the greatest level of reporter certainty. Hypospadias represents a distinct 
phenotype and can be clearly identified by clinicians and, therefore, we selected this 
subset of DDD participants as our study group. Although the HPO classification system 
provides a standardised method to describe phenotype abnormalities in humans and 
allows a comprehensive capture of human phenotype(Kohler et al., 2017), the overlap 
that exists between HPO classes may have given rise to a degree of inter-reporter variation 
in the choice of HPO terms when describing some abnormalities such as those affecting 
the brain. 
 
Reduced androgen exposure in utero as well as other environmental and genetic causes 
are well established contributing factors to the development of isolated hypospadias in 
humans, (Bouty et al., 2015) but hypospadias has also been linked to a large number of 
potentially causative developmental genes, causing a combination of congenital 
abnormalities. Indeed, the Online Mendelian Inheritance in Man (OMIM) database lists 
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283 conditions with hypospadias.(Amberger et al., 2015) The constellation of 
hypospadias, neurodevelopmental delay, cardiovascular abnormalities and brain 
malformations returned 79 different syndromes when entered in combination into the 
London Medical Database (v.1.0.30) while performing a search for ‘syndromes on 
features’.(Suri, 2002) There are several examples of these associations existing together 
as part of well-defined syndromes including Rubinstein-Taybi syndrome 
(RSTS).(Hennekam, 2006, Agarwal et al., 2002, Bonioli et al., 1989), FG 
syndrome,(Fitzky et al., 1998) Mowat-Wilson syndrome(Garavelli and Mainardi, 2007) 
and Lin-Gettig syndrome.(Bashir et al., 2017, Doyon et al., 2006). The genes that are 
associated with pathogenic alterations in these conditions have roles in regulating gene 
expression through mediating or modulating gene transcription (MED12, ZEB2, KAT6B, 
EP300, CREBBP) and epigenetic regulation (KAT6B, EP300, CREBBP) and thus have 
the potential to influence the expression of numerous other genes that may play key roles 
in normal human development. The lack of more detailed clinical information such as 
results of biochemical tests and other endocrine data limited the current study from 
exploring whether the hypospadias was associated with a disorder of gonadal 
development, androgen synthesis or androgen action. However, previous studies suggest 
that associated anomalies are more likely to be associated with a disorder of gonadal 
development.(Cox et al., 2014) 
Whether there is a common pathway responsible for the development of hypospadias, 
neurodevelopmental delay, cardiovascular and structural brain abnormalities together is 
yet to be established and further studies will be required to investigate the association of 
these features. 
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In summary, cardiovascular and structural brain abnormalities are frequently described in 
association with hypospadias in children with developmental disorders. In a substantial 
number of cases, hypospadias, neurodevelopmental, cardiovascular and structural brain 
abnormalities exist as a constellation. While the recognition of phenotypic associations 
with hypospadias might alert clinicians to the possible presence of undetected additional 
clinical problems and thus further improve clinical management, these findings also 
highlight the importance of a multidisciplinary team approach in these complex cases. In 
addition, recognition of these associations may also aid with identifying the underlying 
genetic aetiology. 
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HPO code HPO term 
HP:0001263 Global developmental delay 
HP:0011342 Mild global developmental delay 
HP:0011343 Moderate global developmental delay 
HP:0011344 Severe global developmental delay 
HP:0100543 Cognitive impairment 
HP:0001249 Intellectual disability 
HP:0001256 Intellectual disability,mild 
HP:0002342 Intellectual disability, moderate 
HP:0002187 Intellectual disability, profound 
HP:0006887 Intellectual disability, progressive 
HP:0010864 Intellectual disability, severe 
HP:0002194 Delayed gross motor development 
HP:0001270 Motor delay 
HP:0002376 Developmental regression 
HP:0000735 Impaired social interactions 
HP:0001328 Specific learning disability 
HP:0000750 Delayed speech and language 
development 
HP:0001344 Absent speech 
HP:0002371 Loss of speech 
HP:0006863 Severe expressive language delay 
 
Table 1. List of HPO codes and terms of neurodevelopmental phenotype entries.  
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Phenotype 
Categories 
Cases with ND 
and no 
hypospadias 
N=645 
Cases with ND 
and 
hypospadias, 
N=166 
Chi squared test 
Fisher exact test, 
p value 
2 proportion test 
p value 
Abdominal wall  56 16 0.7594 
 
Pregnancy related  94 20 0.4539 
 
Structural brain 
abnormalities 
92 40 0.003 0.002 
Chest 56 11 0.4339 
 
Cardiovascular 110 47 0.0019 0.001 
Ear 164 36 0.3637 
 
Endocrine 59 20 0.3033 
 
Epilepsy 110 24 0.4825 
 
Eye 394 102 1.00 
 
Face 221 51 0.4081 
 
Gastrointestinal 180 40 0.3784 
 
Growth 194 54 0.5711 
 
Haematological 17 5 0.7895 
 
Hand 221 62 0.4661 
 
Hearing 74 16 0.58 
 
Mouth 230 52 0.316 
 
Neck 15 3 1.00 
 
Neuromuscular 166 31 0.0675 
 
Nose 122 33 0.825 
 
Renal 73 14 0.327 
 
Respiratory 73 21 0.683 
 
Skeletal 292 67 0.293 
 
Skin 152 44 0.418 
 
Skull 222 56 0.927 
 
Voice 2 1 0.497 
 
Other 157 50 0.135 
 
 
Table 2. Number of cases with an abnormality in the disease categories in the two groups 
of neurodevelopmental delay with and without hypospadias and results of statistical 
anlayses showing p values derived from the Fisher exact and 2 proportion tests.  
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  Total         47       
110 
 
 
Table 3. Description of cardiovascular and brain phenotypes encountered in cases of 
neurodevelopmental delay with and without hypospadias.  
  
 
Number of cases in 
group with 
hypospadias   
Number of cases in 
group without 
hypospadias  
Cardiovascular phenotypes   
Septal defects 15 (32%) 37 (34%) 
Combination of large vessel and septal defects 7 (15%) 9 (8%) 
PDA +/- septal defects 7 (15%) 12 (11%) 
Complex combined heart disorders 7 (15%) 21 (19%) 
Abnormalities of the large vessels 4 (8%) 8 (7%) 
Valvular disorders 3 (6%) 7 (6%) 
Other 4 (8%) 16 (14%) 
Structural brain abnormalities   
Complex structural brain defects 15 (37%) 27 (29%) 
Abnormalities of the cerebral ventricles 6 (15%) 14 (15%) 
Cerebral malformations 5 (12%) 18 (20%) 
Cerebellar malformations 3 (7%) 5 (5%) 
Abnormalities of the corpus callosum 3 (7%) 11 (12%) 
Other 8 (20%) 17 (18%) 
  Total 40 92 
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Figure legends 
 
 
Figure 1. DDD participants selected for current study, from top down: DDD participants (n, 13,632), participants with ‘Abnormality of the genital system’ (n, 1,092), participants with hypospadias (n, 245) and participants without hypospadias (n, 847), participants with and without hypospadias who also have neurodevelopmental delay (n, 166 and 645, respectively). 
 
Figure 2. The range of additional phenotype categories in the 166 DDD participants with 
neurodevelopmental delay and hypospadias. 
 
